Compass Therapeutics, Inc. (CMPX)
5.52
+0.08
(+1.47%)
USD |
NASDAQ |
Apr 15, 12:25
Compass Therapeutics EPS Diluted (Quarterly) : -0.085 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0054 |
| Insmed, Inc. | -1.538 |
| Ekso Bionics Holdings, Inc. | -1.568 |
| Definium Therapeutics, Inc. | -0.5106 |
| ImmunityBio, Inc. | -0.0626 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.72M |
| Total Expenses (Quarterly) | 15.72M |
| Enterprise Value | 780.60M |
| Earnings Yield | -7.86% |
| Normalized Earnings Yield | -7.855 |